Member Info for JoeyDiamond

Small fry PIs using their micro share accounts on their phones most likely reacting to Zak Mir.

That RNS made me laugh :)

Momentum building as the herd is jumping in. Big question around the II seller do they have many shares left to sell into the herd momentum?

https://www.telegraph.co.uk/news/2020/10/19/government-secures-20-million-covid-quick-testing-kits/

I don't have a subscription to the Tdelegraph so can't see it , not sure if anyone on here does?

Interesting him talking around 8 minutes on dilution to shareholders. The convertable loan note was preferable to raising cash at current SP levels than via a equity raise. The reason being is he believes SP valuation is too low considering the likely growth to come and he expects a re-rate. So raising funds this way will be better long term.

Fortune comes across as very confident and bullish.

Thanks PL75

On sky news now, Heathrow representitive David Evans advises

Advising the airport test this is a LAMP test rather than PCR.
Will cost £80.
Will have results in 20 mins to 1 hour.
Their will be an antigen test coming later that will cost less than £80.

The test in the airposts cost £80 and results in 1 hour according to sky news.

The media have long given the public the idea herd immunity and a vaccine will be our salvation but in reality evidence is pointing to it being with us always like flu or the common cold.

Neither they are another company based in Canada who are using a nebulised IFNa2b formulation as their drug.

Phase 3 is a hospital only trial for people at score 4 on WHO ordinal scale.

This will not include home trial patients.

Hi Leaf1

I can answer your question. The risk factors are not in the RNS but in the circular.

A copy can be found here http://regulatory.synairgen.com/PressReleases
Titled Circular to shareholders dated 15 October 2020

Page 26 onwards

Very similar to Synairgen, Betterlife on 15th Oct have got a 3rd party on board to commence their next trial in Australia. Dr Eleannor Fish as you recall is invloved with this new drug.

https://www.marketscreener.com/quote/stock/BETTERLIFE-PHARMA-INC-21822450/news/BetterLife-Pharma-Names-CRO-for-COVID-19-Clinical-Trial-in-Australia-31545377/

who are also developing an inhaled form of Interferon Alpha 2b - (AP-003)

Inicdentally are also ramping up manufacturing

https://www.marketscreener.com/quote/stock/BETTERLIFE-PHARMA-INC-21822450/news/BetterLife-Pharma-Scales-up-Manufacturing-of-AP-003-Interferon-Alpha-2b-to-Prepare-for-Clinical-31313046/

Cadila Healthcare Ltd is a giant Indian healthcare company. They have a Pegylated Interferon - a2b in Phase 2 trials.

https://clinicaltrials.gov/ct2/show/NCT04480138

Nothing related to Synairgen just another company developing somethign similar. Bit like the Canadian company Betterlife.

https://clinicaltrials.gov/ct2/show/NCT04469491

Im very happy for Aurélien Mary, MD it looks like he has finally been given the go ahead for his clinical trial in France. To note this trial is by neulization of Inteferon Beta 1b different from SNG001s formulation. He was very postive and excited over Synairgens results.

For some of the board members here will remember he was unhappy at not getting funding. Especially when 3 million Euros was spunked on a pre clinical trial :)

Hi Woodstock. I read the RNS and the Synairgen presentation but couldn't find where it says 2nd quarter next year for results. All I could find was Q4 2020 start date. Could you point me in the right direction. Thx

For reference the previous Phase 2 (hospital arm) was completed in 9 weeks.

This time round there is serious wonga and a specialist 3rd party company lined up to perform the trials so you would expect another quick trial. This supported by FDA / NIH / 20 countries.

They dont have a Covid treatment so not sure the relevence for this board?

Info for Emergency use

https://www.fda.gov/drugs/types-applications/investigational-new-drug-ind-application#Emergency

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-investigational-drug-or-biologic